keyboard_arrow_up

Technological Advancements Will Guarantee Better Results in the Global Digital PCR Market through 2019

Reportstack has announced a new market research report on the Global Digital PCR Market, which is expected to grow at a CAGR of 26.45 percent from 2014-2019.

About the Report

Digital polymerase chain reaction (dPCR) technology provides a higher degree of accuracy and reproducibility in the amplification and analysis of nucleic acids like DNA, RNA and cDNA, than any other PCR technology.

The report emphasizes advances in dPCR technologies and instruments such as improvements in system design that provide a high degree of accuracy and efficiency in sample processing and data analysis. The innovations in dPCR instruments and software help analyze and manage a huge amount of data and provide better quality results.

“Droplet digital polymerase chain reaction (ddPCR), a new and advanced technology, offers complete quantification of target DNA molecules with a high degree of accuracy, precision and sensitivity for quantitative PCR applications,”.

This advanced technology helps researchers complete the drug development process in a shorter time with a higher degree of precision, which will be a major factor contributing to market growth over the projected period.

Key Information Covered in the Report:

Market segmentation, size and forecast through 2019

Market Growth Drivers:

Advances in Technology
For a full detailed list, view our report.

Market Challenges:

Availability of Alternative Technologies
For a full detailed list, view our report.

Market Trends:

Adoption of dPCR
For a full detailed list, view our report.

Key Vendors:

Bio-Rad Laboratories Inc.
Fluidigm Corp.
RainDance Technologies Inc.

Other Prominent Vendors:

Abbott Laboratories
Affymetrix
Becton Dickinson
bioMérieux

To access full report with TOC, please visit Global dPCR (Digital PCR) Market 2015-2019